2016, Number 03
<< Back Next >>
MediSan 2016; 20 (03)
Acral lentiginous melanoma in a suazi woman
Arias BE, Arias BMB, Tellería LYE
Language: Spanish
References: 8
Page: 365-371
PDF size: 133.55 Kb.
ABSTRACT
The case report of a 58 years black woman is presented. She went to the Surgery Service of Mbabane Government Hospital in Suaziland due to a pigmented and ulcerated injury in her right foot heel, where she had an excisional biopsy whose result was an invasive acral lentiginous melanoma. Later on she was evaluated in the Oncology Service and after carrying out the necessary complementary tests, the neoplasm was classified in stage IIC. The patient was referred to South Africa to receive treatment with immunomodulatory cytokines, stimulating factor of granulocytes and macrophages colonies or BRAF gene inhibitors.
REFERENCES
Lavanderos J, Pérez JA, Jeria S, Concha D. Actualizaciones en melanoma maligno cutáneo. Cuad Cir. 2010 [citado 14 Oct 2014]; 24: 47-56.
Swetter SM, Elston DM, Albertini JG. Cutaneous melanoma. Medscape. 2015 Dec [citado 14 Oct 2014].
Burgués Calderón M, Llamas Martín R. Factores de riesgo y detección temprana del melanoma maligno en pacientes con nevus melanocíticos. Más Dermatol. 2011; 14: 5-13.
United States Department of Health and Human Services. National Cancer Institute. Melanoma: Tratamiento-para profesionales de la salud [citado 10 Nov 2014].
Martínez González S. Melanoma maligno cutáneo. Estudio de características morfológicas e inmunohistoquímicas del tumor primario predictivas de metástasis en ganglio centinela [tesis doctoral]. Barcelona: Universidad Autónoma de Barcelona; 2007 [citado 10 Nov 2014].
Gallegos Hernández JF. Melanoma. Fundamentos del diagnóstico y la terapéutica. Acta Médica Grupo Ángeles. 2012; 10(4): 207-13.
Tan WW, Talavera F, Elston DM. Malignant melanoma [citado 3 Oct 2014].
Tomás Mallebrera L, Rojo España R, Marquina Vila A, Gimeno Clemente N, Morales Suárez Varela MM. Sentinel lymph node biopsy in patients with melanoma. Actas Dermosifiliogr. 2010; 101(5): 428-36.